After having a short / Trump squeeze in Nov, it pulled back to $5 and formed a double bottom with a high volume spike in December. It started to move out of the double bottom when broke the regression channel in the end of Jan.
Now its clearly above the neckline and daily ma. I may start a small position in it today and double down if it retest 5.50 area. Stop will be db low with price target at $7 and $8. This in the beaten up healthcare sector.
Now its clearly above the neckline and daily ma. I may start a small position in it today and double down if it retest 5.50 area. Stop will be db low with price target at $7 and $8. This in the beaten up healthcare sector.
評論:
company could be in danger of being delisted for Nasdaq.